Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Gene expression profiles in COVID-19-associated tracheal stenosis indicate persistent anti-viral response and dysregulated retinol metabolism.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Biomed Central Country of Publication: England NLM ID: 101462768 Publication Model: Electronic Cited Medium: Internet ISSN: 1756-0500 (Electronic) Linking ISSN: 17560500 NLM ISO Abbreviation: BMC Res Notes Subsets: MEDLINE
    • Publication Information:
      Original Publication: London : Biomed Central, 2008.
    • Subject Terms:
    • Abstract:
      Introduction: Coronavirus disease 2019 (COVID-19)-associated tracheal stenosis (COATS) may occur as a result of prolonged intubation during COVID-19 infection. We aimed to investigate patterns of gene expression in the tracheal granulation tissue of patients with COATS, leverage gene expression data to identify dysregulated cellular pathways and processes, and discuss potential therapeutic options based on the identified gene expression profiles.
      Methods: Adult patients (age ≥ 18 years) presenting to clinics for management of severe, recalcitrant COATS were included in this study. RNA sequencing and differential gene expression analysis was performed with transcriptomic data for normal tracheal tissue being used as a control. The top ten most highly upregulated and downregulated genes were identified. For each of these pathologically dysregulated genes, we identified key cellular pathways and processes they are involved in using Gene Ontology (GO) and KEGG (Kyoto Encyclopedia of Genes and Genomes) applied via Database for Annotation, Visualization, and Integrated Discovery (DAVID).
      Results: Two women, aged 36 years and 37 years, were included. The profile of dysregulated genes indicated a cellular response consistent with viral infection (CXCL11, PI15, CCL8, DEFB103A, IFI6, ACOD1, and DEFB4A) and hyperproliferation/hypergranulation (MMP3, CASP14 and HAS1), while downregulated pathways included retinol metabolism (ALDH1A2, RBP1, RBP4, CRABP1 and CRABP2).
      Conclusion: Gene expression changes consistent with persistent viral infection and dysregulated retinol metabolism may promote tracheal hypergranulation and hyperproliferation leading to COATS. Given the presence of existing literature highlighting retinoic acid's ability to favorably regulate these genes, improve cell-cell adhesion, and decrease overall disease severity in COVID-19, future studies must evaluate its utility for adjunctive management of COATS in animal models and clinical settings.
      (© 2024. The Author(s).)
    • References:
      J Cell Biochem. 2010 Feb 15;109(3):487-97. (PMID: 19960512)
      J Dermatol Sci. 2014 Nov;76(2):112-9. (PMID: 25240866)
      Infect Disord Drug Targets. 2021;21(6):e170721187996. (PMID: 33200717)
      Proc Nutr Soc. 1999 May;58(2):289-93. (PMID: 10466169)
      Int Heart J. 2007 May;48(3):369-78. (PMID: 17592201)
      Biomed Res Int. 2014;2014:609086. (PMID: 24877120)
      Biochem Biophys Res Commun. 2010 Aug 6;398(4):713-8. (PMID: 20621062)
      Bioorg Med Chem Lett. 2001 Feb 26;11(4):571-4. (PMID: 11229774)
      JCI Insight. 2016 Apr;1(4):e86355. (PMID: 27158675)
      J Invest Dermatol. 2005 Dec;125(6):1236-41. (PMID: 16354194)
      Med Hypotheses. 2020 Nov;144:110250. (PMID: 33254555)
      J Immunol. 2005 Jun 1;174(11):7376-82. (PMID: 15905585)
      Eur Arch Otorhinolaryngol. 2021 Jan;278(1):1-7. (PMID: 32506145)
      Nutrients. 2021 Jun 24;13(7):. (PMID: 34202697)
      Br J Ophthalmol. 2015 Apr;99(4):561-5. (PMID: 25614514)
      Am J Transl Res. 2020 Aug 15;12(8):4739-4748. (PMID: 32913546)
      J Invest Dermatol. 1995 Jun;104(6):902-9. (PMID: 7769256)
      Mol Genet Genomic Med. 2020 Jun;8(6):e1245. (PMID: 32309912)
      Crit Care. 2021 Dec 27;25(1):448. (PMID: 34961537)
      Ann Thorac Surg. 1971 Oct;12(4):359-74. (PMID: 4939117)
      J Invest Dermatol. 2008 Apr;128(4):797-807. (PMID: 17943186)
      Anesth Pain Med. 2021 Jul 09;11(3):e115868. (PMID: 34540642)
      Allergy. 2022 Jan;77(1):118-129. (PMID: 33993490)
      Rheumatology (Oxford). 2004 Feb;43(2):164-9. (PMID: 13130151)
      Zhonghua Yi Xue Za Zhi. 2019 Jun 25;99(24):1898-1903. (PMID: 31269587)
      J Cell Biol. 2008 Feb 11;180(3):451-8. (PMID: 18250198)
      J Nutr Biochem. 2013 May;24(5):832-41. (PMID: 22925918)
      JAMA Otolaryngol Head Neck Surg. 2016 Nov 1;142(11):1082-1087. (PMID: 27532803)
      Am J Med. 1981 Jan;70(1):65-76. (PMID: 7457492)
      Laryngoscope. 2006 Sep;116(9):1553-7. (PMID: 16954977)
      J Pharmacol Exp Ther. 2006 May;317(2):506-13. (PMID: 16436497)
      Bioorg Med Chem Lett. 2007 Dec 1;17(23):6521-4. (PMID: 17933532)
      J Thorac Cardiovasc Surg. 1995 Mar;109(3):486-92; discussion 492-3. (PMID: 7877309)
      Eur J Dermatol. 2003 Nov-Dec;13(6):560-70. (PMID: 14721776)
      J Med Chem. 1999 May 6;42(9):1525-36. (PMID: 10229623)
      J Clin Nurs. 2024 Jan;33(1):6-10. (PMID: 34369020)
      Aging (Albany NY). 2020 Aug 15;12(15):15784-15796. (PMID: 32805728)
      Infect Disord Drug Targets. 2023;23(1):e190622206159. (PMID: 35726419)
      Am J Physiol Lung Cell Mol Physiol. 2009 Aug;297(2):L340-6. (PMID: 19465517)
      Cardiovasc Pathol. 2008 Mar-Apr;17(2):72-80. (PMID: 18329551)
      Int J Pharm. 2008 May 22;356(1-2):110-20. (PMID: 18280068)
      Transl Cancer Res. 2020 Mar;9(3):2099-2101. (PMID: 35117564)
      J Biol Chem. 1999 Aug 27;274(35):24881-7. (PMID: 10455161)
      Prev Med. 2019 May;122:91-99. (PMID: 31078178)
      J Invest Dermatol. 2002 Nov;119(5):1150-5. (PMID: 12445205)
      Br J Nutr. 2021 Dec 14;126(11):1663-1672. (PMID: 33468263)
      Am J Rhinol Allergy. 2015 Nov-Dec;29(6):430-4. (PMID: 26637582)
      Clin Nutr Open Sci. 2022 Jun;43:85-94. (PMID: 35664529)
      Laryngoscope. 2021 Dec;131(12):E2880-E2886. (PMID: 34117778)
      Laryngoscope. 1979 Mar;89(3):482-9. (PMID: 107382)
      Arch Iran Med. 2017 Sep;20(9):598-607. (PMID: 29048922)
      J Bronchology Interv Pulmonol. 2023 Apr 01;30(2):176-179. (PMID: 35916435)
      Exp Gerontol. 2006 Jun;41(6):641-7. (PMID: 16723203)
      Genomics. 1997 Aug 1;43(3):339-48. (PMID: 9268637)
      Ann Otol Rhinol Laryngol. 2004 Jun;113(6):488-97. (PMID: 15224835)
    • Contributed Indexing:
      Keywords: Coronavirus disease 2019; Endotracheal intubation; Granulation tissue; Molecular medicine; RNA; Subglottic stenosis
    • Publication Date:
      Date Created: 20240516 Date Completed: 20240517 Latest Revision: 20240519
    • Publication Date:
      20240519
    • Accession Number:
      PMC11100031
    • Accession Number:
      10.1186/s13104-024-06775-y
    • Accession Number:
      38755665